Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Travel Vaccines Global Market Report 2025
Download Free Sample Buy Now
Global Travel Vaccines Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Travel Vaccines Global Market Report 2025

By Disease (Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,), By Composition (Mono Vaccines, Combination Vaccines), By Booking Channel (Online Booking, In-Person Booking), By Application (Domestic Travel, Outbound Travel) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Travel Vaccines Market Overview

• Travel Vaccines market size has reached to $4.73 billion in 2024

• Expected to grow to $7.36 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%

• Growth Driver: Surge In Travel And Tourism Drives Growth Of The Travel Vaccine Market

• Market Trend: Takeda's QDENGA Approval Marks A Milestone In Travel Vaccine Innovation

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Travel Vaccines Market?

Travel vaccines are vaccines to protect against diseases that are either indigenous to the country of origin or the country of destination. They function to safeguard travelers and stop the spread of disease both within and between nations.

The main travel vaccines available to treat diseases include hepatitis A, diphtheria, Pertussis, and tetanus (DPT), yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, and others. Hepatitis A is a disease caused by the hepatitis A virus (HAV), which results in inflammation of the liver. They are composed of mono vaccines and combination vaccines booked by online booking, in-person booking channels for domestic travel, and outbound travel applications.

Travel Vaccines Market Size and growth rate 2025 to 2029: Graph

What Is The Travel Vaccines Market Size 2025 And Growth Rate?

The travel vaccines market size has grown strongly in recent years. It will grow from $4.73 billion in 2024 to $5.09 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased international travel, government initiatives for travel health, globalization of diseases, growing awareness among travelers, and expansion of the travel and tourism industry

What Is The Travel Vaccines Market Growth Forecast?

The travel vaccines market size is expected to see strong growth in the next few years. It will grow to $7.36 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to the increasing frequency of business travel, emerging infectious disease threats, government regulations and entry requirements, rising demand for exotic destinations, and collaboration between governments and pharmaceutical companies. Major trends in the forecast period include tailored vaccination strategies, expansion of the market to non-endemic regions, adoption of digital health technologies, regulatory support, and streamlined approvals, innovative developments.

The forecast of 9.6% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Import restrictions could challenge U.S. travel clinics by raising costs of yellow fever vaccines and typhoid immunization products manufactured in France and Belgium, compromising protection for international travelers. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Travel Vaccines Market Segmented?

1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,

2) By Composition: Mono Vaccines, Combination Vaccines

3) By Booking Channel: Online Booking, In-Person Booking

4) By Application: Domestic Travel, Outbound Travel

Subsegments:

1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines

2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)

3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines

4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine

5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines

6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine

7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)

8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine

9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

What Is Driving The Travel Vaccines Market? Surge In Travel And Tourism Drives Growth Of The Travel Vaccine Market

The increase in travel and tourism is expected to propel the growth of the travel vaccine market going forward. Travel and tourism refer to the movement of people or things, including vehicles like trains, boats, airplanes, and other conveyances, between various remote geographic areas. Travel vaccines are helpful for tourists and travelers by keeping them safe and healthy while they are traveling abroad. For instance, in January 2023, according to the United Nations World Tourism Organization (UNWTO), a Spain-based intergovernmental tourism-promoting organization, more than 900 million tourists traveled abroad in 2022, double the amount recorded in 2021 but still 63% higher than pre-pandemic levels. Therefore, the increase in travel and tourism is driving the growth of the travel vaccine industry.

What Is Driving The Travel Vaccines Market? Surge In Healthcare Spending Propels Growth Of The Travel Vaccine Market

The increase in healthcare spending is driving the growth of the travel vaccine market. Healthcare spending refers to the total amount of financial resources allocated to the healthcare sector within a specific region, country, or organization. Healthcare spending includes investment in travel vaccines as a preventive measure, reducing the economic burden of treating travel-related diseases. Travel vaccines contribute to public health by minimizing the risk of infectious diseases during international travel, thus avoiding the costs associated with medical treatment, hospitalization, and potential outbreaks upon return. For instance, in September 2024, according to the statistics published by Cross River Therapy, a US-based provider of ABA therapy services, the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medicine in 2021, and projected spending is expected to increase to $605-$635 billion by 2025. Therefore, an increase in healthcare spending is driving the growth of the travel vaccine industry going forward.

Who Are The Major Players In The Global Travel Vaccines Market?

Major companies operating in the travel vaccines market include Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Biological E. Limited, Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc.

What Are The Key Trends Of The Global Travel Vaccines Market? Takeda's QDENGA Approval Marks A Milestone In Travel Vaccine Innovation

Product innovation is a key trend gaining popularity in the travel vaccine market. Major companies operating in the travel vaccine market are developing innovative vaccines to sustain their position in the market. For instance, in August 2022, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, got the approval for QDENGA (Dengue Tetravalent Vaccine) (TAK-003), for the prevention of dengue sickness caused by any serotype in people aged six to 45 from Indonesia National Agency for Drug and Food Control. Regardless of a person's prior exposure to the disease, QDENGA showed three years after immunization that it remained to provide overall protection against dengue sickness and hospitalization.

What Are The Key Trends Of The Global Travel Vaccines Market? Innovative Travel Vaccines Prevent Hepatitis A For Travelers And Children

Major companies operating in the travel vaccine market are developing innovative vaccines to provide active immunization to prevent Hepatitis A common concern for travelers. A travel vaccine is a vaccine specifically designed to protect individuals from infectious diseases that are prevalent in certain regions or countries, often recommended for travelers visiting those areas. For instance, in January 2024, Indian Immunologicals Ltd. (IIL), an India-based biotechnology company, launched Havisure, India’s first indigenously developed Hepatitis A vaccine. Havisure is anticipated to be instrumental in providing protection against the Hepatitis A virus, which mainly impacts the liver. This vaccine is effective in preventing the disease and is advised for children as part of routine immunization. Additionally, it is recommended for individuals at risk of exposure or those traveling to areas with high rates of hepatitis A.

Need data on a specific region in this market?
Request Regional Data

Travel Vaccines Market Merger And Acquisition: Bavarian Nordic Bolsters Travel Vaccine Portfolio With Acquisition Of Emergent Biosolutions' Assets

In May 2023, Bavarian Nordic, a US-based biopharmaceutical company, acquired Emergent BioSolutions’ travel vaccine portfolio for an undisclosed amount. With the acquisition, Bavarian Nordic gained two commercially available vaccines-Vivotif for the prevention of typhoid fever and Vaxchora for the prevention of cholera as well as a Phase 3 vaccine candidate for the prevention of the Chikungunya virus. The acquisition also includes US-based R&D facilities, a Swiss biologics production facility, and EU and US commercial operations with a specialized salesforce. Emergent BioSolutions is a US-based biotechnology firm that specializes in manufacturing, and developing devices, vaccines, therapeutics, and contract manufacturing and travel vaccines is a business division of the company.

Regional Outlook For The Global Travel Vaccines Market

North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Travel Vaccines Market?

The travel vaccine market consists of sales of vaccines for diseases such as Japanese encephalitis, tick-borne encephalitis, and tuberculosis (TB). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Travel Vaccines Industry?

The travel vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the travel vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Travel Vaccines Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $5.09 billion
Revenue Forecast In 2034 $7.36 billion
Growth Rate CAGR of 9.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel Subsegments: 1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines
2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)
3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines
4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine
5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines 6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine 7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP) 8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine 9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Biological E. Limited, Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Travel Vaccines Market Characteristics

3. Travel Vaccines Market Trends And Strategies

4. Travel Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Travel Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Travel Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Travel Vaccines Market Growth Rate Analysis

5.4. Global Travel Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Travel Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Travel Vaccines Total Addressable Market (TAM)

6. Travel Vaccines Market Segmentation

6.1. Global Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hepatitis A

Diphtheria, Pertussis, And Tetanus (DPT)

Yellow Fever

Typhoid

Hepatitis B

Measles And Mumps

Rabies

Meningococcal

Other Diseases

6.2. Global Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mono Vaccines

Combination Vaccines

6.3. Global Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Online Booking

In-Person Booking

6.4. Global Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Domestic Travel

Outbound Travel

6.5. Global Travel Vaccines Market, Sub-Segmentation Of Hepatitis A, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inactivated Hepatitis A Vaccine

Combination Vaccines

6.6. Global Travel Vaccines Market, Sub-Segmentation Of Diphtheria, Pertussis, And Tetanus (DPT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inactivated Hepatitis A Vaccine

Combination Vaccines

6.7. Global Travel Vaccines Market, Sub-Segmentation Of Yellow Fever, By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Live Attenuated Yellow Fever Vaccine

Booster Dosage Vaccines

6.8. Global Travel Vaccines Market, Sub-Segmentation Of Typhoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inactivated Typhoid Vaccine

Live Attenuated Typhoid Vaccine

6.9. Global Travel Vaccines Market, Sub-Segmentation Of Hepatitis B, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Recombinant Hepatitis B Vaccine

Combination Vaccines

6.10. Global Travel Vaccines Market, Sub-Segmentation Of Measles And Mumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Measles, Mumps, And Rubella (MMR) Vaccine

Measles And Rubella (MR) Vaccine

6.11. Global Travel Vaccines Market, Sub-Segmentation Of Rabies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rabies Pre-exposure Prophylaxis (PrEP)

Rabies Post-exposure Prophylaxis (PEP)

6.12. Global Travel Vaccines Market, Sub-Segmentation Of Meningococcal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Meningococcal Conjugate Vaccine

Meningococcal B Vaccine

6.13. Global Travel Vaccines Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Japanese Encephalitis

Cholera

Influenza

Other Emerging Travel Vaccines

7. Travel Vaccines Market Regional And Country Analysis

7.1. Global Travel Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Travel Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Travel Vaccines Market

8.1. Asia-Pacific Travel Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Travel Vaccines Market

9.1. China Travel Vaccines Market Overview

9.2. China Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Travel Vaccines Market

10.1. India Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Travel Vaccines Market

11.1. Japan Travel Vaccines Market Overview

11.2. Japan Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Travel Vaccines Market

12.1. Australia Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Travel Vaccines Market

13.1. Indonesia Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Travel Vaccines Market

14.1. South Korea Travel Vaccines Market Overview

14.2. South Korea Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Travel Vaccines Market

15.1. Western Europe Travel Vaccines Market Overview

15.2. Western Europe Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Travel Vaccines Market

16.1. UK Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Travel Vaccines Market

17.1. Germany Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Travel Vaccines Market

18.1. France Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Travel Vaccines Market

19.1. Italy Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Travel Vaccines Market

20.1. Spain Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Travel Vaccines Market

21.1. Eastern Europe Travel Vaccines Market Overview

21.2. Eastern Europe Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Travel Vaccines Market

22.1. Russia Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Travel Vaccines Market

23.1. North America Travel Vaccines Market Overview

23.2. North America Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Travel Vaccines Market

24.1. USA Travel Vaccines Market Overview

24.2. USA Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Travel Vaccines Market

25.1. Canada Travel Vaccines Market Overview

25.2. Canada Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Travel Vaccines Market

26.1. South America Travel Vaccines Market Overview

26.2. South America Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Travel Vaccines Market

27.1. Brazil Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Travel Vaccines Market

28.1. Middle East Travel Vaccines Market Overview

28.2. Middle East Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Travel Vaccines Market

29.1. Africa Travel Vaccines Market Overview

29.2. Africa Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Travel Vaccines Market Competitive Landscape And Company Profiles

30.1. Travel Vaccines Market Competitive Landscape

30.2. Travel Vaccines Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Travel Vaccines Market Other Major And Innovative Companies

31.1. Biological E. Limited

31.2. Takeda Pharmaceutical Company Limited

31.3. Novavax Inc.

31.4. Emergent BioSolutions UK

31.5. Serum Institute of India Pvt. Ltd.

31.6. Dynavax Technologies

31.7. Bavarian Nordic A/S

31.8. Valneva SE

31.9. Panacea Biotec

31.10. Vabiotech

31.11. Inovio Pharmaceuticals

31.12. Bharat Biotech International Limited

31.13. Altimmune Inc.

31.14. Bio Farma

31.15. Vaxart Inc.

32. Global Travel Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Travel Vaccines Market

34. Recent Developments In The Travel Vaccines Market

35. Travel Vaccines Market High Potential Countries, Segments and Strategies

35.1 Travel Vaccines Market In 2029 - Countries Offering Most New Opportunities

35.2 Travel Vaccines Market In 2029 - Segments Offering Most New Opportunities

35.3 Travel Vaccines Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Travel Vaccines Market, Sub-Segmentation Of Hepatitis A, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Travel Vaccines Market, Sub-Segmentation Of Diphtheria, Pertussis, And Tetanus (DPT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Travel Vaccines Market, Sub-Segmentation Of Yellow Fever, By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Travel Vaccines Market, Sub-Segmentation Of Typhoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Travel Vaccines Market, Sub-Segmentation Of Hepatitis B, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Travel Vaccines Market, Sub-Segmentation Of Measles And Mumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Travel Vaccines Market, Sub-Segmentation Of Rabies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Travel Vaccines Market, Sub-Segmentation Of Meningococcal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Travel Vaccines Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Travel Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Global Travel Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Asia-Pacific, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: China, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: India, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Japan, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Australia, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Indonesia, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: South Korea, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Western Europe, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: UK, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Germany, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: France, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Italy, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Spain, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Eastern Europe, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Russia, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: North America, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: USA, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Canada, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: South America, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Brazil, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Middle East, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Africa, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 84: Pfizer Inc. Financial Performance
  • Table 85: Johnson and Johnson Financial Performance
  • Table 86: Merck & Co. Inc. Financial Performance
  • Table 87: Sanofi SA Financial Performance
  • Table 88: GlaxoSmithKline plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Travel Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Travel Vaccines Market, Sub-Segmentation Of Hepatitis A, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Travel Vaccines Market, Sub-Segmentation Of Diphtheria, Pertussis, And Tetanus (DPT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Travel Vaccines Market, Sub-Segmentation Of Yellow Fever, By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Travel Vaccines Market, Sub-Segmentation Of Typhoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Travel Vaccines Market, Sub-Segmentation Of Hepatitis B, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Travel Vaccines Market, Sub-Segmentation Of Measles And Mumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Travel Vaccines Market, Sub-Segmentation Of Rabies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Travel Vaccines Market, Sub-Segmentation Of Meningococcal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Travel Vaccines Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Travel Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Global Travel Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Asia-Pacific, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: China, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: India, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Japan, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Australia, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Indonesia, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: South Korea, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Western Europe, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: UK, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Germany, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: France, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Italy, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Spain, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Eastern Europe, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Russia, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: North America, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: USA, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Canada, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: South America, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Brazil, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Middle East, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Travel Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Travel Vaccines Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Africa, Travel Vaccines Market, Segmentation By Booking Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 84: Pfizer Inc. Financial Performance
  • Figure 85: Johnson and Johnson Financial Performance
  • Figure 86: Merck & Co. Inc. Financial Performance
  • Figure 87: Sanofi SA Financial Performance
  • Figure 88: GlaxoSmithKline plc Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

View Report

Vaccine Delivery Devices Global Market Report 2025 – By Type Of Device (Needle Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches And Microinjectors), By Route Of Ad...

View Report

Therapeutic BCG Vaccines Global Market Report 2025 – By Type (Therapy BCG, Immune BCG), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users ) – Impact of Tariff and Trade War on Market S...

View Report

Preventive Vaccines Global Market Report 2025 - By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By Disease Ty...

View Report

Ruminant Vaccines Global Market Report 2025 – By Vaccine Type (Inactivated Vaccines, Attenuated Or Modified Live Vaccines, Other Vaccine Types), By Indication (Bovine Respiratory Diseases (BRD), Diarrhea Or Scours, Foot-...

View Report

Pediatric Vaccine Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, C...

View Report

Adult Vaccines Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vac...

View Report

Travel Vaccines Global Market Report 2025 – By Disease (Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,), By Compositio...

View Report

Frequently Asked Questions

Travel vaccines are vaccines to protect against diseases that are either indigenous to the country of origin or the country of destination. They function to safeguard travelers and stop the spread of disease both within and between nations. For further insights on this market, request a sample here

The market major growth driver - Surge In Travel And Tourism Drives Growth Of The Travel Vaccine Market. For further insights on this market, request a sample here

The travel vaccines market size has grown strongly in recent years. It will grow from $4.73 billion in 2024 to $5.09 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased international travel, government initiatives for travel health, globalization of diseases, growing awareness among travelers, and expansion of the travel and tourism industry The travel vaccines market size is expected to see strong growth in the next few years. It will grow to " $7.36 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to the increasing frequency of business travel, emerging infectious disease threats, government regulations and entry requirements, rising demand for exotic destinations, and collaboration between governments and pharmaceutical companies. Major trends in the forecast period include tailored vaccination strategies, expansion of the market to non-endemic regions, adoption of digital health technologies, regulatory support, and streamlined approvals, innovative developments. For further insights on this market, request a sample here

The travel vaccines market covered in this report is segmented –
1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel Subsegments:
1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines
2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)
3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines
4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine
5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines
6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine
7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)
8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine
9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines For further insights on this market, request a sample here

North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the travel vaccines market include Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Biological E. Limited, Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc. . For further insights on this market, request a sample here.

Major trends in this market include Takeda's QDENGA Approval Marks A Milestone In Travel Vaccine Innovation. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Travel Vaccines Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon